Published in Virology on September 01, 1982
P85gag-mos encoded by ts110 Moloney murine sarcoma virus has an associated protein kinase activity. Proc Natl Acad Sci U S A (1983) 1.95
S1 nuclease mapping of viral RNAs from a temperature-sensitive transformation mutant of murine sarcoma virus. J Virol (1984) 1.16
Murine sarcoma virus ts110 RNA transcripts: origin from a single proviral DNA and sequence of the gag-mos junctions in both the precursor and spliced viral RNAs. J Virol (1985) 1.11
Temperature-sensitive viral RNA expression in Moloney murine sarcoma virus ts110-infected cells. J Virol (1985) 1.05
Temperature-sensitive splicing defect of ts110 Moloney murine sarcoma virus is virus encoded. J Virol (1986) 0.92
Molecular basis underlying phenotypic revertants of Moloney murine sarcoma virus MuSVts110. J Virol (1986) 0.89
Detection of an 85,000-dalton phosphoprotein in ts110 murine sarcoma virus-infected cells with antiserum against a v-mos peptide. J Virol (1983) 0.83
P85: a gag-mos polyprotein encoded by ts110 Moloney murine sarcoma virus. J Virol (1983) 0.83
Reversion of thermosensitive splicing defect of Moloney murine sarcoma virus ts110 by oversplicing of viral RNA. J Virol (1990) 0.75
Further characterization of intracellular precursor polyproteins of Rauscher leukemia virus. Virology (1977) 4.06
Transcription of ribonucleic acid in isolated mouse myeloma nuclei. Biochemistry (1973) 3.59
Biosynthesis of Rauscher leukemia viral proteins. Cell (1975) 3.57
Biosynthesis of Rauscher leukemia viral proteins: presence of p30 and envelope p15 sequences in precursor polypeptides. Virology (1976) 3.20
"gag" polyprotein precursors of Rauscher murine leukemia virus. Virology (1977) 2.95
Common precursor for Rauscher leukemia virus gp69/71, p15(E), and p12(E). J Virol (1977) 2.73
A fucose-deficient glycoprotein precursor to Rauscher leukemia virus gp69/71. Proc Natl Acad Sci U S A (1976) 2.22
P85gag-mos encoded by ts110 Moloney murine sarcoma virus has an associated protein kinase activity. Proc Natl Acad Sci U S A (1983) 1.95
Proteins of Rauscher murine leukemia virus: resolution of a 70,000-dalton, Nonglycosylated polypeptide containing p30 peptide sequences. Virology (1975) 1.91
Purification of large amounts of murine ribonucleic acid tumor viruses produced in roller bottle cultures. Appl Microbiol (1972) 1.83
Cell-free synthesis of a precursor polyprotein containing both gag and pol gene products by Rauscher murine leukemia virus 35S RNA. Cell (1978) 1.71
Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D. J Virol (1976) 1.69
Serine kinase activity associated with Maloney murine sarcoma virus-124-encoded p37mos. Virology (1985) 1.67
The cell-free translation of Rauscher leukemia virus RNA into high molecular weight polypeptides. Biochim Biophys Acta (1975) 1.65
Novel GACG-hairpin pair motif in the 5' untranslated region of type C retroviruses related to murine leukemia virus. J Virol (1992) 1.64
Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients. Oncogene (2009) 1.64
Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation. Oncogene (2001) 1.63
Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients. Leukemia (2002) 1.62
Tryptic peptide analysis of gag and gag-pol gene products of Rauscher murine leukemia virus. J Virol (1979) 1.61
Endodeoxyribonuclease activity associated with Rauscher murine leukemia virus. J Virol (1981) 1.61
Cells transformed by certain strains of Moloney sarcoma virus contain murine p60. Cell (1977) 1.56
Extraparenchymal neurocysticercosis: report of five cases and review of management. Clin Infect Dis (1992) 1.50
A subset of Pr65gag is nucleus associated in murine leukemia virus-infected cells. J Virol (1993) 1.49
Expression of p21ras in fresh primary and metastatic human colorectal tumors. Proc Natl Acad Sci U S A (1985) 1.47
Foot-and-mouth disease virus-induced ribonucleic acid polymerase in baby hamster kidney cells. Virology (1967) 1.46
The isolation of two enzyme-ribonucleic acid complexes involved in the synthesis of foot-and-mouth disease virus ribonucleic acid. Proc Natl Acad Sci U S A (1969) 1.45
A selective temperature-sensitive defect in viral RNA expression in cells infected with a ts transformation mutant of murine sarcoma virus. Cell (1981) 1.43
Characterization of 40,000- and 25,000-dalton intermediate precursors to Rauscher murine leukemia virus gag gene products. J Virol (1979) 1.40
The cyclin B2 component of MPF is a substrate for the c-mos(xe) proto-oncogene product. Cell (1990) 1.35
Transcription of the genes for 5S ribosomal RNA and transfer RNA in isolated mouse myeloma cell nuclei. Biochemistry (1974) 1.30
Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia. Blood (1994) 1.23
Inhibition of human immunodeficiency virus type 1 infection and syncytium formation in human cells by V3 loop synthetic peptides from gp120. J Virol (1993) 1.22
Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism. Leukemia (2008) 1.21
Ribosomes from Rauscher leukemia virus-infected cells and their response to Rauscher viral RNA and polyuridylic acid. Biochim Biophys Acta (1973) 1.19
Identification of molecular variants of p210bcr-abl in chronic myelogenous leukemia. Blood (1987) 1.18
Biosynthesis of reverse transcriptase from Rauscher murine leukemia virus by synthesis and cleavage of a gag-pol read-through viral precursor polyprotein. Proc Natl Acad Sci U S A (1978) 1.17
Further characterization of the P85gag-mos -associated protein kinase activity. Virology (1984) 1.17
S1 nuclease mapping of viral RNAs from a temperature-sensitive transformation mutant of murine sarcoma virus. J Virol (1984) 1.16
Fractionation of mouse myeloma chromatin. Biochemistry (1973) 1.15
Structural components of a virus of the California encephalitis complex: LaCrosse virus. Virology (1973) 1.14
Inhibition of cell-free foot-and-mouth disease virus-ribonucleic acid synthesis by antibody. Virology (1967) 1.12
Murine sarcoma virus ts110 RNA transcripts: origin from a single proviral DNA and sequence of the gag-mos junctions in both the precursor and spliced viral RNAs. J Virol (1985) 1.11
Processing of the env gene products of Moloney murine leukaemia virus. J Gen Virol (1982) 1.11
Electron microscopic analysis of ts1 10 Moloney mouse sarcoma virus, a variant of wild-type virus with two RNAs containing large deletions. J Mol Biol (1982) 1.10
Regulation of AML2/CBFA3 in hematopoietic cells through the retinoic acid receptor alpha-dependent signaling pathway. J Biol Chem (1999) 1.08
Use of site-specific antipeptide antibodies to perturb the serine kinase catalytic activity of p37mos. J Virol (1985) 1.07
Detergent-solubilized RNA polymerase from cells infected with foot-and-mouth disease virus. Science (1967) 1.07
p37mos-associated serine/threonine protein kinase activity correlates with the cellular transformation function of v-mos. J Virol (1986) 1.06
Sequence of events in the transformation process in cells infected with a temperature-sensitive transformation mutant of Moloney murine sarcoma virus. Proc Natl Acad Sci U S A (1981) 1.05
Temperature-sensitive viral RNA expression in Moloney murine sarcoma virus ts110-infected cells. J Virol (1985) 1.05
BCR-ABL tyrosine kinase is autophosphorylated or transphosphorylates P160 BCR on tyrosine predominantly within the first BCR exon. Oncogene (1993) 1.04
Recognition of mos-related proteins with an antiserum to a peptide of the v-mos gene product. J Gen Virol (1985) 1.03
BCR gene expression blocks Bcr-Abl induced pathogenicity in a mouse model. Oncogene (2001) 1.02
Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148). Clin Cancer Res (1998) 1.02
Studies on foot-and-mouth disease virus ribonucleic acid synthesis. Virology (1966) 1.01
Presynaptic effect of I.V. anaesthetic agents at the neuromuscular junction. Br J Anaesth (1979) 1.01
Probing the mechanism of staphylococcal nuclease with unnatural amino acids: kinetic and structural studies. Science (1993) 1.00
P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells. Oncogene (1990) 0.99
Inhibition of ribonucleic acid methylation in the foot-and-mouth disease virus-infected host cell. Biochem Biophys Res Commun (1967) 0.99
P210 Bcr-Abl interacts with the interleukin 3 receptor beta(c) subunit and constitutively induces its tyrosine phosphorylation. Cancer Res (1996) 0.98
Site of foot-and-mouth disease virus-ribonucleic acid synthesis and some properties of its double-stranded ribonucleic acid. Biochim Biophys Acta (1968) 0.98
Identification of the protein product of the c-mos proto-oncogene in mouse testes. Oncogene (1988) 0.98
Characterization of virus-specified proteins present in NRK cells infected with a temperature-sensitive transformation mutant of Moloney murine sarcoma virus. Cold Spring Harb Symp Quant Biol (1980) 0.97
A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia. Blood (1996) 0.96
In vitro products of a membrane-free foot-and-mouth disease virus ribonucleic acid polymerase. Virology (1969) 0.96
RNA polymerase complexes from mengovirus infected cells. Arch Gesamte Virusforsch (1972) 0.95
Characterization of MEK1 phosphorylation by the v-Mos protein. Oncogene (1995) 0.95
Changes in protein and nucleic acid metabolism in baby hamster kidney cells infected with foot-and-mouth disease virus. Arch Gesamte Virusforsch (1968) 0.95
The histidine-221 to tyrosine substitution in v-mos abolishes its biological function and its protein kinase activity. Virology (1988) 0.95
Rapid in vivo induction of HIV-specific CD8+ cytotoxic T lymphocytes by a 15-amino acid unmodified free peptide from the immunodominant V3-loop of GP120. Virology (1992) 0.94
Tryptic peptide analyses of polypeptides generated by premature termination of cell-free protein synthesis allow a determination of the Rauscher leukemia virus gag gene order. J Virol (1978) 0.94
Exploitation of a thermosensitive splicing event to study pre-mRNA splicing in vivo. Mol Cell Biol (1988) 0.94
Inhibition of Bcr serine kinase by tyrosine phosphorylation. Mol Cell Biol (1996) 0.94
Gag-mos Polyproteins encoded by variants of the Moloney strain of mouse sarcoma virus. Virology (1983) 0.94
Moloney murine sarcoma virus encoded p37mos expressed in yeast has protein kinase activity. Virology (1986) 0.94
Regulation of RNA splicing in gag-deficient mutants of Moloney murine sarcoma virus MuSVts110. J Virol (1990) 0.94
The translation products of Moloney murine sarcoma virus-124 RNA. Virology (1980) 0.93
Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients. Cancer Res (1987) 0.93
Localization of a novel tumor suppressor locus on human chromosome 3q important in osteosarcoma tumorigenesis. Cancer Res (1997) 0.93
Vimentin phosphorylation by p37mos protein kinase in vitro and generation of a 50-kDa cleavage product in v-mos-transformed cells. Virology (1989) 0.92
Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model. Vaccine (2001) 0.92
Multilineage involvement of Philadelphia chromosome positive acute lymphoblastic leukemia. Leukemia (1998) 0.92
Temperature-sensitive splicing defect of ts110 Moloney murine sarcoma virus is virus encoded. J Virol (1986) 0.92
Identification of T-cell epitopes without B-cell activity in the first and second conserved regions of the HIV Env protein. AIDS (1991) 0.91
Chronic myelogenous leukemia blast cell proliferation is inhibited by peptides that disrupt Grb2-SoS complexes. Blood (2001) 0.91
Branchpoint and polypyrimidine tract mutations mediating the loss and partial recovery of the Moloney murine sarcoma virus MuSVts110 thermosensitive splicing phenotype. J Virol (1995) 0.90
In vitro proteolytic cleavage of Gazdar murine sarcoma virus p65gag. J Virol (1981) 0.90